Cargando…
Radioimmunoimaging of (125)I-labeled anti-CD93 monoclonal antibodies in a xenograft model of non-small cell lung cancer
Lung cancer, especially non-small cell lung cancer (NSCLC), is the most common malignant tumor associated with poor prognosis. Angiogenesis plays a vital role in NSCLC, and could be used in tumor staging and therapy evaluation. CD93 (C1q receptor) is reportedly a key regulator of tumor angiogenesis....
Autores principales: | Liu, Weiwei, Zhang, Chao, Cao, Hui, Shi, Dai, Zhao, Shanshan, Liang, Ting, Hou, Guihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896371/ https://www.ncbi.nlm.nih.gov/pubmed/31819775 http://dx.doi.org/10.3892/ol.2019.11036 |
Ejemplares similares
-
TLR5 is a new reporter for triple‐negative breast cancer indicated by radioimmunoimaging and fluorescent staining
por: Shi, Dai, et al.
Publicado: (2019) -
A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging
por: Yamamura, Miyuki, et al.
Publicado: (1996) -
Radioimmunoimaging of Liver Metastases with PET Using a (64)Cu-Labeled CEA Antibody in Transgenic Mice
por: Nittka, Stefanie, et al.
Publicado: (2014) -
Influence of Cocktails of Labeled Monoclonal Antibodies on the Localization of Antibodies in Human Tumor Xenografts
por: Watanabe, Yuji, et al.
Publicado: (1990) -
CD93 in macrophages: A novel target for atherosclerotic plaque imaging?
por: Su, Chen, et al.
Publicado: (2022)